(Total Views: 251)
Posted On: 03/27/2017 6:38:15 PM
Post# of 72436
yes. absolutely.
Quote:
Does anyone know if Fast Track designation from FDA can be used after Phase II if there is an unmet medical need? I had forgotten about the PR below.
November 25, 2015
FDA Grants Fast Track Designation to Cellceutix’s Brilacidin-OM for Oral Mucositis.
Read More: investorshangout.com/post/view?id=4440918#ixzz4cZJwTGrG
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)